Scibase AB (SCIB) - Total Assets
Based on the latest financial reports, Scibase AB (SCIB) holds total assets worth Skr53.98 Million SEK (≈ $5.81 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See SCIB net assets for net asset value and shareholders' equity analysis.
Scibase AB - Total Assets Trend (2012–2024)
This chart illustrates how Scibase AB's total assets have evolved over time, based on quarterly financial data.
Scibase AB - Asset Composition Analysis
Current Asset Composition (December 2024)
Scibase AB's total assets of Skr53.98 Million consist of 90.9% current assets and 9.1% non-current assets.
| Asset Category | Amount (SEK) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Skr11.24 Million | 18.2% |
| Accounts Receivable | Skr35.92 Million | 58.2% |
| Inventory | Skr8.32 Million | 13.5% |
| Property, Plant & Equipment | Skr5.64 Million | 9.1% |
| Intangible Assets | Skr0.00 | 0.0% |
| Goodwill | Skr0.00 | 0.0% |
Asset Composition Trend (2012–2024)
This chart illustrates how Scibase AB's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Scibase AB market cap and net worth.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Scibase AB's current assets represent 90.9% of total assets in 2024, a decrease from 95.7% in 2012.
- Cash Position: Cash and equivalents constituted 18.2% of total assets in 2024, down from 74.2% in 2012.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2012.
- Asset Diversification: The largest asset category is accounts receivable at 58.2% of total assets.
Scibase AB Competitors by Total Assets
Key competitors of Scibase AB based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Demant A/S
CO:DEMANT
|
Denmark | Dkr39.07 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Beijing Wandong Medical Technology Co Ltd
SHG:600055
|
China | CN¥5.70 Billion |
|
Sinocare Inc
SHE:300298
|
China | CN¥6.25 Billion |
|
MODULIGHT OY EO 1
F:78W
|
Germany | €49.14 Million |
|
Diagnostic Medical Systems SA
PA:ALDMS
|
France | €57.17 Million |
|
Theradiag SA
PA:ALTHE
|
France | €11.55 Million |
|
Nova EYE Medical Ltd
AU:EYE
|
Australia | AU$23.67 Million |
Scibase AB - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.49 | 3.10 | 4.96 |
| Quick Ratio | 2.07 | 2.44 | 4.31 |
| Cash Ratio | 1.23 | 1.54 | 0.00 |
| Working Capital | Skr30.13 Million | Skr33.73 Million | Skr42.20 Million |
Scibase AB - Advanced Valuation Insights
This section examines the relationship between Scibase AB's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 8.09 |
| Latest Market Cap to Assets Ratio | 0.30 |
| Asset Growth Rate (YoY) | -4.0% |
| Total Assets | Skr61.73 Million |
| Market Capitalization | $18.23 Million USD |
Valuation Analysis
Below Book Valuation: The market values Scibase AB's assets below their book value (0.30x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: Scibase AB's assets decreased by 4.0% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Scibase AB (2012–2024)
The table below shows the annual total assets of Scibase AB from 2012 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | Skr61.73 Million ≈ $6.64 Million |
-4.05% |
| 2023-12-31 | Skr64.33 Million ≈ $6.92 Million |
+29.04% |
| 2022-12-31 | Skr49.85 Million ≈ $5.37 Million |
-41.66% |
| 2021-12-31 | Skr85.46 Million ≈ $9.20 Million |
+44.23% |
| 2020-12-31 | Skr59.25 Million ≈ $6.38 Million |
+28.36% |
| 2019-12-31 | Skr46.16 Million ≈ $4.97 Million |
-43.09% |
| 2018-12-31 | Skr81.11 Million ≈ $8.73 Million |
-36.59% |
| 2017-12-31 | Skr127.91 Million ≈ $13.77 Million |
+25.27% |
| 2016-12-31 | Skr102.11 Million ≈ $10.99 Million |
-33.37% |
| 2015-12-31 | Skr153.25 Million ≈ $16.49 Million |
+268.29% |
| 2014-12-31 | Skr41.61 Million ≈ $4.48 Million |
-4.73% |
| 2013-12-31 | Skr43.68 Million ≈ $4.70 Million |
+82.97% |
| 2012-12-31 | Skr23.87 Million ≈ $2.57 Million |
-- |
About Scibase AB
SciBase Holding AB (publ), a medical technology company, develops and commercializes point-of-care platforms for skin health management in Europe, the United States, North America, Asia, Oceania, and internationally. It operates through Skin Cancer and Skin Barrier Assessment segments. The company offers Nevisense and Nevisense Go point-of-care platforms to detect melanoma and non-melanoma skin c… Read more